More tools:Markets·Screener·Research·Chat

Vericel Corporation (VCEL) Financial Statements

Vericel Corporation
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001S6X9M3
XNAS · usd
39.08▼ 1.11 (-2.76%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close40.19
Day's Range38.74 – 39.72
52-Week Range28.95 – 49.32
Volume409.8K
Avg Volume481.9K
Share Statistics
Shares Outstanding
Employees398
ExchangeXNAS
Listed1997-02-04
Share count as of July 24, 2026
Loading Income Statement…
Key questions about Vericel Corporation (VCEL)
What is Vericel Corporation's Market Cap?
Vericel Corporation's Market Cap is $2.0B, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Enterprise Value?
Vericel Corporation's Enterprise Value is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Trailing P/E?
Vericel Corporation's Trailing P/E is 82.6×, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Price / Sales?
Vericel Corporation's Price / Sales is 6.5×, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's EV / Revenue?
Vericel Corporation's EV / Revenue is 6.0×, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's EV / EBITDA?
Vericel Corporation's EV / EBITDA is 60.9×, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Revenue (TTM)?
Vericel Corporation's Revenue (TTM) is $306.3M, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Net Income (TTM)?
Vericel Corporation's Net Income (TTM) is $24.2M, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's EBITDA?
Vericel Corporation's EBITDA is $31.2M, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Diluted EPS (TTM)?
Vericel Corporation's Diluted EPS (TTM) is 0.47, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Product sales, net
YoY growth+22.5%+30.1%+23.3%+16.6%
Total revenue
Cost of product sales
Gross profit
% of revenue72.8%72.0%78.7%73.5%
Research and development
Selling, general and administrative
Total operating expenses
% of revenue72.3%83.8%54.6%68.3%
Income (loss) from operations
% of revenue0.6%-11.8%24.1%5.1%
Other income (expense):
Interest income
Interest expense
Other income (expense)
Total other income
Net income (loss)
% of revenue2.8%-9.2%25.0%7.5%
Basic (in USD per share)
Diluted (in USD per share)